Document Detail


Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians.
MedLine Citation:
PMID:  12586125     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The management of patients who require temporary interruption of oral anticoagulant therapy because of surgery or other invasive procedures is a clinically important topic because of the increasing prevalence of patients who are receiving oral anticoagulants and the availability of low-molecular-weight heparins (LMWHs), which allow out-of-hospital perioperative anticoagulation. The optimal management of such patients has been hampered by the lack of well-designed prospective studies investigating the efficacy and safety of different perioperative management strategies. The two main issues that need to be considered in perioperative anticoagulant management is the patient's risk of thromboembolic event when anticoagulant therapy is interrupted and the risk of bleeding that is associated with the surgery or procedure. An assessment of these factors will determine the perioperative management approach. The objectives of this review are to focus on practical issues relating to perioperative anticoagulation and the implementation of a perioperative anticoagulation management approach that can be used in everyday clinical practice.
Authors:
James D Douketis
Related Documents :
20095295 - Swallowing problems and dementia in acute hospital settings: practical guidance for the...
17432775 - Management of the anxious patient: what treatments are available?
20088305 - Traumatic complete urethral disruption: the west virginia experience.
20072035 - Evaluation of a new spine classification system, does it accurately predict treatment?
21467245 - The acceptability of 'trauma risk management' within the uk armed forces.
23066755 - Climate forecasts in disaster management: red cross flood operations in west africa, 2008.
Publication Detail:
Type:  Case Reports; Comment; Journal Article; Review    
Journal Detail:
Title:  Thrombosis research     Volume:  108     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2003-02-14     Completed Date:  2003-11-28     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3-13     Citation Subset:  IM    
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada. jdouket@mcmaster.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Anticoagulants / administration & dosage*
Atrial Fibrillation / complications,  drug therapy
Blood Loss, Surgical / prevention & control
Female
Heart Valve Prosthesis / adverse effects
Heparin, Low-Molecular-Weight / administration & dosage
Humans
International Normalized Ratio
Kidney Failure / drug therapy
Middle Aged
Perioperative Care*
Postoperative Hemorrhage / etiology,  prevention & control
Risk Factors
Thromboembolism / drug therapy
Thrombosis / blood,  etiology,  prevention & control
Venous Thrombosis / drug therapy
Warfarin / administration & dosage
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Heparin, Low-Molecular-Weight; 81-81-2/Warfarin
Comments/Corrections
Comment On:
Thromb Res. 2002 Oct 1;108(1):1-2   [PMID:  12586124 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The loss of the chemical tanker Ievoli Sun in the English Channel, October 2000.
Next Document:  Changes of biochemical markers and functional tests for clot formation during long-haul flights.